Cargando…
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
AIM: We tested the hypothesis that left ventricular hypertrophy (LVH) interferes with the antithrombotic effects of dabigatran and warfarin in patients with atrial fibrillation (AF). METHODS AND RESULTS: This is a post-hoc analysis of the Randomized Evaluation of Long-term anticoagulation therapY (R...
Autores principales: | Verdecchia, Paolo, Reboldi, Gianpaolo, Angeli, Fabio, Mazzotta, Giovanni, Lip, Gregory Y H, Brueckmann, Martina, Kleine, Eva, Wallentin, Lars, Ezekowitz, Michael D, Yusuf, Salim, Connolly, Stuart J, Di Pasquale, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834147/ https://www.ncbi.nlm.nih.gov/pubmed/28520924 http://dx.doi.org/10.1093/europace/eux022 |
Ejemplares similares
-
Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial
por: Hijazi, Ziad, et al.
Publicado: (2019) -
Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial
por: Reinhardt, Samuel W., et al.
Publicado: (2021) -
Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
por: Avezum, Alvaro, et al.
Publicado: (2018) -
Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons
por: Verdecchia, Paolo, et al.
Publicado: (2014) -
Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
por: Angeli, Fabio, et al.
Publicado: (2019)